Cardiff Oncology, Inc. (NASDAQ: CRDF) had an eventful trading day, starting with a minor decline of 3.02% before rallying strongly by 33.71% in the afterhours.
Shares of Cardiff Oncology, Inc. (NASDAQ: CRDF) were traded up 39.59% after it announced that Onvansertib has shown the clinical benefit in colorectal cancer. The
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.